Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 57

Sort by

Sort Order Select

Journal Articles

Central Nervous System Involvement in Aggressive ATLL: Can We Predict the Risk in a Devastating Complication? Epidemiology and Clinical Features from Latin America. a Collaborative Study from Grupo De Estudio Latino-Americano De Linfoproliferativo (GELL) & T-Cell Brazil Project (TCBP)

Natalia Pin Chuen Zing, Thais Fischer, Eliana Miranda, Maria Almeida Dias, Yung Gonzaga, Renata Lyrio R Baptista, Guilherme D Amarante, Rony Schaffel, Frederico Lisboa Nogueira, Davimar Bortucchi, Rodrigo Santucci, Sergio Brasil, Karin Z Cecyn, Vera Figueiredo, Nelson S Castro, Yana S Rabelo, Gilnara Fontinele Silva, Abrahão Elias Hallack Neto, Patricia Giacon, Milene Matedi, Diego Vila Cle, Juliana Pereira, Fernando Barroso, Renata R Souza, Henry Quintero, Denisse Castro, Brady E Beltran, Daniel J Enriquez, Jule F Vasquez, Claudia Roche, Daniel Artiles, Fabiola Valverte, Luis Mario Villela, Ana Carolina Oliver, Laura Korin, Macarena Roa, Camila Peña, Maria Alejandra Torres Viera, Alana Von Glasenapp, Alfredo Quiroz, Cesar Samanez-Figari, Rosa Oliday Rios Jimenez, Sally Paredes, Eduardo Edelman Saul, Casey Bermack, Kelly Meza, Bryan Valcarcel, Carmino De Souza, Luis Malpica, Carlos Chiattone

Blood (2024) 144 (Supplement 1): 3064.

https://doi.org/10.1182/blood-2024-211630

Published: 2024

Journal Articles

The Impact of Social Determinants and Diagnostic Inequities in Hodgkin Lymphoma Outcomes: A Comparative Analysis of South America and the United States

Blood (2024) 144 (Supplement 1): 2370.

https://doi.org/10.1182/blood-2024-203230

Published: 2024

Journal Articles

Refining Prognostication in Peripheral T Cell Lymphoma (PTCL): A Risk-Adapted Prognostic Model for Patients with Limited-Stage PTCL

Carolina Romero, Macarena Roa, Henry Idrobo, Denisse Castro, Brady E Beltran, Daniel J Enriquez, Jule F Vasquez, Claudia Roche, Daniel Artiles, Fabiola Valvert, Luis Mario Villela Martinez, Juliana Pereira, Ana Carolina Oliver, Jamila Vaz Tavarez, Sergio Augusto B Brasil, Karin Z Cecyn, Nelson S Castro, Renata Lyrio R Baptista, Samuel S. Medina, Davimar Miranda Maciel Borducchi, Marcelo Bellesso, Danielle Leão Cordeiro De Farias, Yung Gonzaga, Laura Korin, Patricio Pereyra, Camila Peña, Maria Alejandra Torres Viera, Kelly Meza, Seisha Von Glasenapp, Alfredo Quiroz, Cesar Samanez-Figari, Rosa Oliday Rios Jimenez, Sally Paredes, Thais Fischer, Asaad Trabolsi, Jonathan H. Schatz, Swaminathan P Iyer, Ranjit Nair, Eduardo Edelman Saul, Casey Bermack, Jorge J. Castillo, Carmino De Souza, Eliana Miranda, Bryan Valcarcel, Carlos Chiattone, Luis Enrique Malpica Castillo

Blood (2024) 144 (Supplement 1): 983.

https://doi.org/10.1182/blood-2024-205295

Published: 2024

Journal Articles

Clinical Features, Therapy Patterns and Survival Outcomes of Limited-Stage Peripheral T-Cell Lymphomas: A Cross-Continental Study

Juan Esteban Garcia-Robledo, Henry Quintero, Denisse Castro, Brady E Beltran, Daniel J Enriquez, Jule F Vasquez, Claudia Roche, Daniel Artiles, Fabiola Valvert, Luis Mario Villela Martinez, Juliana Pereira, Ana Carolina Oliver, Jamila Vaz Tavarez, Sergio Augusto B Brasil, Karin Z Cecyn, Nelson S Castro, Renata Lyrio R Baptista, Samuel S. Medina, Davimar Miranda Maciel Borducchi, Marcelo Bellesso, Danielle Leão Cordeiro De Farias, Yung Gonzaga, Laura Korin, Patricio Pereyra, Camila Peña, Macarena Roa, Maria Alejandra Torres Viera, Kelly Meza, Seisha Von Glasenapp, Alfredo Quiroz, Cesar Samanez-Figari, Rosa Oliday Rios Jimenez, Sally Paredes, Thais Fischer, Asaad Trabolsi, Jonathan H. Schatz, Swaminathan P Iyer, Ranjit Nair, Eduardo Edelman Saul, Casey Bermack, Jorge J. Castillo, Carmino De Souza, Eliana Miranda, Bryan Valcarcel, Carlos Chiattone, Luis Enrique Malpica Castillo

Blood (2024) 144 (Supplement 1): 1687.

https://doi.org/10.1182/blood-2024-205881

Published: 2024

Journal Articles

Validating the Halp Score (Hemoglobin,Albumin, Lymphocytes, and Platelets) and the Neutrophil/Lymphocyte Ratio ( NLR ) As Prognostic Factors for Overall Survival in Patients with Diffuse Large B-Cell Lymphoma. Retrospective Analysis By the Grupo De Estudio De Latino America De Linfoproliferativos (GELL)

Blood (2023) 142 (Supplement 1): 1757.

https://doi.org/10.1182/blood-2023-188265

Published: 2023

Journal Articles

Clinical Features, Treatment Patterns and Outcomes of 864 Newly Diagnosed Hodgkin Lymphoma Patients in Latin America and the Impact of PET Scan Availability on Survival: A Study from the Grupo De Estudio Latinoamericano De Linfoproliferativos (GELL)

Blood (2023) 142 (Supplement 1): 4441.

https://doi.org/10.1182/blood-2023-185131

Published: 2023

Journal Articles

Real-World Data on the Clinical Features, Therapy Patterns and Outcomes of 651 Elderly Patients with Diffuse Large B-Cell Lymphoma in Latin America: A Study from the Grupo De Estudio Latinoamericano De Linfoproliferativos (GELL)

Blood (2023) 142 (Supplement 1): 1748.

https://doi.org/10.1182/blood-2023-187049

Published: 2023

Journal Articles

Prognostic Significance of the Neutrophil/Lymphocyte Ratio in Diffuse Large B-Cell Lymphoma: A Systematic Review and Meta-Analysis

Rafael Martin De Jesus Pichardo Rodriguez, Brady E Beltran, Luis Vilela, Marialejandra Torres Viera, Jhony A. De La Cruz-Vargas, Oscar Ruiz-Franco, Jorge J. Castillo, Luis Enrique Malpica Castillo

Blood (2023) 142 (Supplement 1): 6303.

https://doi.org/10.1182/blood-2023-185194

Published: 2023

Journal Articles

Validating the Systemic Inmmune-Inflamation Index (SII) As a Prognostic Biomarker of Overall Survival in Diffuse Large B-Cell Lymphoma: A Retrospective Analyses By the Gruppo De Estudio Latinoamericano De Linfoproliferativos (GELL)

Blood (2023) 142 (Supplement 1): 1775.

https://doi.org/10.1182/blood-2023-188015

Published: 2023

Journal Articles

Validating the Prognostic Value of Anemia and Thrombocytopenia in Latin American Patients with Diffuse Large B-Cell Lymphoma: A Study from the Grupo De Estudio Latinoamericano De Linfoproliferativos (GELL)

Blood (2022) 140 (Supplement 1): 6708–6710.

https://doi.org/10.1182/blood-2022-168165

Published: 2022

Journal Articles

Diffuse Large B-Cell Lymphoma (DLBCL) in the Elderly: Real World Experience in Latin America. A Study from the Grupo De Estudio Latinoamericano De Linfoproliferativos (GELL)

Blood (2022) 140 (Supplement 1): 6697–6698.

https://doi.org/10.1182/blood-2022-162389

Published: 2022

Journal Articles

Evolution of Treatment Patterns and Prognostic Biomarkers in Latin American Patients with Chronic Lymphocytic Leukemia: A Study By the Grupo De Estudio Latinoamericano De Linfoproliferativos (GELL)

Blood (2022) 140 (Supplement 1): 10918–10920.

https://doi.org/10.1182/blood-2022-168276

Published: 2022

Journal Articles

Genomic Profiling and Clinicopathological Features in Peruvian Patients with EBV-Positive Diffuse Large B-Cell Lymphomas, NOS

Denisse Castro, Brady E. Beltrán, Sally Rose Paredes, Marco Lopez, Maria del Pilar Quiñones

Blood (2022) 140 (Supplement 1): 11909.

https://doi.org/10.1182/blood-2022-170923

Published: 2022

Journal Articles

Progression of Disease within 5 Months of Adult T-Cell Leukemia-Lymphoma (ATL5) As a Clinical Endpoint for High-Risk Mortality Outcomes in the Real-World Setting: A Multinational Cohort Analysis

Bryan Valcarcel, Haruhiko Sano, Hiroo Katsuya, Atae Utsunomiya, Maki Otsuka, Masaharu Miyahara, Yasushi Takamatsu, Kenji Ishitsuka, Shinya Kimura, Junji Suzumiya, Kazuo Tamura, Daniel J Enriquez, Denisse Castro, Brady E Beltran, Henry Idrobo, Camila Peña, Lorena Fiad, Juan Carlos Ramos, Luis Enrique Malpica Castillo

Blood (2022) 140 (Supplement 1): 6664–6665.

https://doi.org/10.1182/blood-2022-168101

Published: 2022

Journal Articles

Treatment Patterns and Survival of Patients with Relapsed and Refractory Classical Hodgkin Lymphoma in Latin America

Seisha Alana Von Glasenapp Gossen, Humberto Martinez-Cordero, Luis Villela, Perla Rocio Colunga-Pedraza, Fernando Perez-Jacobo, Arianna Robles, Diego Fernando Garces PAZ, Henry Idrobo, Denisse Castro, Sally Rose Paredes, Brady E Beltran, Ana Carolina Oliver, Victoria Irigoin, Juan Alejandro Ospina, Rosa Oliday Rios

Blood (2022) 140 (Supplement 1): 9429–9430.

https://doi.org/10.1182/blood-2022-171102

Published: 2022

Journal Articles

Clinical Features, Treatment Patterns, and Outcomes Among 837 Patients with Adult T-Cell Leukemia-Lymphoma in the Real-World Setting: A Comparison of Endemic Regions

Blood (2022) 140 (Supplement 1): 1072–1073.

https://doi.org/10.1182/blood-2022-168334

Published: 2022

Journal Articles

Notable Patterns in the Genomic Landscape of Adult T-Cell Leukemia/Lymphoma Encountered in HTLV-1 Endemic Western World Regions

Blood (2021) 138 (Supplement 1): 810.

https://doi.org/10.1182/blood-2021-154275

Published: 2021

Journal Articles

Serum Albumin and Neutrophil-to-Lymphocyte Ratio, Two Independent Factor Predicting Survival in Patients with Follicular Lymphoma: A Multi-Institutional Retrospective Cohort of 741 FL, from the Latin American Lymphoproliferative Study Group (GELL)

Blood (2021) 138 (Supplement 1): 4515.

https://doi.org/10.1182/blood-2021-149662

Published: 2021

Journal Articles

Clinico-Epidemiological Features of Elderly Patients with Peripheral T-Cell Lymphoma Not Otherwise Specified: A Study from the Grupo De Estudio Latinoamericano De Linfoproliferativos (GELL)

Henry Idrobo, Denisse Castro, Lorena Fiad, Yesenia M. Huerta- Collado, Victoria Otero, Sally Rose Paredes, Juan Esteban Garcia-Robledo, Juan Felipe Lasso, Humberto Martinez-Cordero, Ana Maria Osorio-Gomez, Julian Andres Sanchez-Perea, Bryan Valcarcel, Luis Villela, Marialejandra Alejandra Torres Viera, Brady E Beltran, Jorge J. Castillo, Luis Malpica-Castillo

Blood (2021) 138 (Supplement 1): 2468.

https://doi.org/10.1182/blood-2021-153849

Published: 2021

Journal Articles

Evaluating the Prognostic Value of Inflammatory Biomarkers and Traditional Prognostic Tools in PTCL: A National, Multicenter Retrospective Study

Sally Rose Paredes, Denisse Castro, Thanya Runciman, Yesenia M. Huerta- Collado, Brady E Beltran, Marco Antonio Zuñiga, Jorge J. Castillo, Bryan Valcarcel, Luis Malpica Castillo

Blood (2021) 138 (Supplement 1): 2474.

https://doi.org/10.1182/blood-2021-152414

Published: 2021

NARROW

Central Nervous System Involvement in Aggressive ATLL: Can We Predict the Risk in a Devastating Complication? Epidemiology and Clinical Features from Latin America. a Collaborative Study from Grupo De Estudio Latino-Americano De Linfoproliferativo (GELL) & T-Cell Brazil Project (TCBP)

The Impact of Social Determinants and Diagnostic Inequities in Hodgkin Lymphoma Outcomes: A Comparative Analysis of South America and the United States

Refining Prognostication in Peripheral T Cell Lymphoma (PTCL): A Risk-Adapted Prognostic Model for Patients with Limited-Stage PTCL

Clinical Features, Therapy Patterns and Survival Outcomes of Limited-Stage Peripheral T-Cell Lymphomas: A Cross-Continental Study

Clinical Features, Treatment Patterns and Outcomes of 864 Newly Diagnosed Hodgkin Lymphoma Patients in Latin America and the Impact of PET Scan Availability on Survival: A Study from the Grupo De Estudio Latinoamericano De Linfoproliferativos (GELL)

Real-World Data on the Clinical Features, Therapy Patterns and Outcomes of 651 Elderly Patients with Diffuse Large B-Cell Lymphoma in Latin America: A Study from the Grupo De Estudio Latinoamericano De Linfoproliferativos (GELL)

Prognostic Significance of the Neutrophil/Lymphocyte Ratio in Diffuse Large B-Cell Lymphoma: A Systematic Review and Meta-Analysis

Validating the Systemic Inmmune-Inflamation Index (SII) As a Prognostic Biomarker of Overall Survival in Diffuse Large B-Cell Lymphoma: A Retrospective Analyses By the Gruppo De Estudio Latinoamericano De Linfoproliferativos (GELL)

Validating the Prognostic Value of Anemia and Thrombocytopenia in Latin American Patients with Diffuse Large B-Cell Lymphoma: A Study from the Grupo De Estudio Latinoamericano De Linfoproliferativos (GELL)

Diffuse Large B-Cell Lymphoma (DLBCL) in the Elderly: Real World Experience in Latin America. A Study from the Grupo De Estudio Latinoamericano De Linfoproliferativos (GELL)

Evolution of Treatment Patterns and Prognostic Biomarkers in Latin American Patients with Chronic Lymphocytic Leukemia: A Study By the Grupo De Estudio Latinoamericano De Linfoproliferativos (GELL)

Genomic Profiling and Clinicopathological Features in Peruvian Patients with EBV-Positive Diffuse Large B-Cell Lymphomas, NOS

Progression of Disease within 5 Months of Adult T-Cell Leukemia-Lymphoma (ATL5) As a Clinical Endpoint for High-Risk Mortality Outcomes in the Real-World Setting: A Multinational Cohort Analysis

Treatment Patterns and Survival of Patients with Relapsed and Refractory Classical Hodgkin Lymphoma in Latin America

Clinical Features, Treatment Patterns, and Outcomes Among 837 Patients with Adult T-Cell Leukemia-Lymphoma in the Real-World Setting: A Comparison of Endemic Regions

Notable Patterns in the Genomic Landscape of Adult T-Cell Leukemia/Lymphoma Encountered in HTLV-1 Endemic Western World Regions

Serum Albumin and Neutrophil-to-Lymphocyte Ratio, Two Independent Factor Predicting Survival in Patients with Follicular Lymphoma: A Multi-Institutional Retrospective Cohort of 741 FL, from the Latin American Lymphoproliferative Study Group (GELL)

Clinico-Epidemiological Features of Elderly Patients with Peripheral T-Cell Lymphoma Not Otherwise Specified: A Study from the Grupo De Estudio Latinoamericano De Linfoproliferativos (GELL)

Evaluating the Prognostic Value of Inflammatory Biomarkers and Traditional Prognostic Tools in PTCL: A National, Multicenter Retrospective Study

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only